[BDRX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -89.99%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 343 674 1,938 989 1,323 1,375 157 13.89%
PBT -23,470 -10,923 -12,400 -12,970 -8,388 -11,232 -9,840 15.57%
Tax 1,281 1,785 2,032 1,265 2,227 1,133 1,018 3.90%
NP -22,189 -9,138 -10,368 -11,705 -6,161 -10,099 -8,822 16.60%
Tax Rate - - - - - - - -
Total Cost 22,532 9,812 12,306 12,694 7,484 11,474 8,979 16.55%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -6,469.10 -1,355.79 -534.98 -1,183.52 -465.68 -734.47 -5,619.11 2.37%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -4,143.60 -3,988.65 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -4,143.60 -3,988.65 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.